Chinese Company Gets Warning Letter After Barring FDA Investigators

Drug Industry Daily
A A
A pharmaceutical company in Beijing has received a warning letter from the FDA after barring investigators from the facility as well as falsifying and backdating records.

To View This Article:

Login

Subscribe To Drug Industry Daily